# Beta Glucan Cold Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/beta-glucan-cold-meta-analysis-evidence-review
Category: evidence-review
Summary: Beta Glucan Cold Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomiz
Last reviewed: 2026-06-15
Reviewed by: Migaku Evidence Review
# Beta Glucan Cold Meta-analysis: What the Evidence Says

## Quick Answer

Beta Glucan Cold Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Dietary β-1,3/1,6-Glucan from Baker’s Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial | randomized trial | 2 | 2026-03-18 | 10.3390/nu18060961 |
| Could β-glucans enhance the immune response to SARS-CoV-2 vaccine by inducing trained immunity and boosting neutralizing antibody production? | research article | 4 | 2026-02-27 | 10.3389/fimmu.2026.1675094 |

## What The Sources Report

- β-1,3-D-glucan (BG) is an essential polysaccharide found in the cell walls of most fungi, some bacteria, and both higher and lower plants. [Kanno Takashi (2026); evidence level 2]
- In mammals, fungal BG is recognized by the host immune system as a pathogen-associated molecular pattern and binds to the host's C-type lectin receptor Dectin-1, inducing immune processes, including inflammation and phagocytosis. [Kanno Takashi (2026); evidence level 2]
- Recent systematic reviews and meta-analyses have consolidated evidence that TCM may serve as an adjunctive therapy in different stages of COVID-19, although robust clinical trials remain necessary to confirm its efficacy as a vaccine adjuvant (-). [Golim Márjorie de Assis (2026); evidence level 4]
- Although immune memory is a peculiar feature of the acquired immune system, activation of the innate system can also result in a greater capacity to respond to subsequent stimuli. [Golim Márjorie de Assis (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For beta glucan cold meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kanno Takashi (2026). Dietary β-1,3/1,6-Glucan from Baker’s Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. DOI: 10.3390/nu18060961. PMCID: PMC13028741. PMID: 41901136. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13028741/
- Golim Márjorie de Assis (2026). Could β-glucans enhance the immune response to SARS-CoV-2 vaccine by inducing trained immunity and boosting neutralizing antibody production?. DOI: 10.3389/fimmu.2026.1675094. PMCID: PMC12984508. PMID: 41836368. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12984508/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.